Journal

Journal of labelled compounds & radiopharmaceuticals
ISSN: 1099-1344
Titre abrégé: J Labelled Comp Radiopharm
Pays: England
ID NLM: 7610510

Informations de publication

Date de publication:
30 06 2019
Historique:
received: 31 01 2019
revised: 04 04 2019
accepted: 09 04 2019
pubmed: 17 4 2019
medline: 29 4 2020
entrez: 17 4 2019
Statut: ppublish

Résumé

We report the design, synthesis, and evaluation of a new series of benzylpiperazine derivatives as selective σ

Identifiants

pubmed: 30991462
doi: 10.1002/jlcr.3738
doi:

Substances chimiques

Fluorine Radioisotopes 0
Ligands 0
Piperazines 0
Receptors, sigma 0
1-benzylpiperazine 3UG152ZU0E
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-437

Subventions

Organisme : National Natural Science Foundation of China
ID : 21876013
Pays : International
Organisme : National Natural Science Foundation of China
ID : 21471019
Pays : International

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jiajun Ye (J)

Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China.

Liang Wang (L)

Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China.

Winnie Deuther-Conrad (W)

Institute of Radiopharmaceutical Cancer Research, Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.

Yuanyuan Chen (Y)

Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China.

Xiaojun Zhang (X)

Nuclear Medicine Department, Chinese PLA General Hospital, Beijing, China.

Jinming Zhang (J)

Nuclear Medicine Department, Chinese PLA General Hospital, Beijing, China.

Yiyun Huang (Y)

Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.

Peter Brust (P)

Institute of Radiopharmaceutical Cancer Research, Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.

Hongmei Jia (H)

Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH